Q3 2023 Vimian Group AB Earnings Call Transcript
Welcome to Vimian Group Q3 Report 2023. For the first part of the conference call, the participants will be in listen-only mode. (Operator Instructions). Now I will hand the conference over to the speakers. Please go ahead.
()-
Welcome to Vimian Third Quarter Earnings Call. I'm Fredrik Ullman, CEO. And with me today is our CFO, Carl-Johan Boudrie today. We also have Magnus Kjellberg here with us, the CEO of our Specialty Pharma segment, Nextmune. And after the Q3 presentation, he will give you a brief update on Nextmune and its development since our IPO. Please move to next slide. So in the third quarter, we reported strong organic growth of 12%, which is well ahead of the animal health market. We continued our efforts to improve cash flow and delivered $11.6 million in cash from operating activities in the quarter.
Our net profit increased to EUR 7.6 million. The adjusted EBITDA margin of 22.9% primarily reflects our sales pattern in MedTech and a mix impact from our U.S.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
